4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-026864
Chief Commercial Officer bought 1,032 shares at $2.48 ($2,561)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baldry Mark Chief Commercial Officer | 2025-05-16 | Purchase | +1,032 | $2.48 | $2,561 | 25,337 | D |
| Open-market purchases · 1,032 sh · avg $2.48 · $2,561 | |||||||
Loading xslF345X05/wk-form4_1747774254.xml…